For women struggling with poor egg quality or diminished ovarian reserve, PRP ovarian rejuvenation is emerging as one of the most promising developments in modern reproductive medicine. By injecting concentrated platelets directly into the ovaries, PRP therapy enhances blood flow and stimulates the growth of healthy follicles, with research indicating that it can lead to improved ovarian function and egg quality. 

PRP for egg quality is most often recommended for patients with diminished ovarian reserve, those who have experienced multiple failed IVF cycles due to low egg or embryo quality, or patients who consistently produce fewer mature eggs per cycle. The procedure itself is straightforward and minimally invasive. A small blood sample is drawn and placed in a centrifuge to separate platelets from red and white blood cells, and the concentrated PRP is then injected into the targeted area, often during the same visit. 

PRP's improving effects typically begin around two weeks after the procedure and can last up to approximately three months, during which patients may see improved ovarian response. Patients who may benefit include women with low AMH, premature ovarian insufficiency, thin endometrial lining, repeated IVF failure, or women over 40 exploring additional fertility options beyond standard protocols.